The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids.
D001095:Arachidonic Acids / Q000378:metabolism*; D006801:Humans; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000096:biosynthesis*; D011457:Prostaglandins D; D011458:Prostaglandins E; D011460:Prostaglandins F; D011480:Protease Inhibitors / Q000494:pharmacology*; D013929:Thromboxane B2; D014105:Tosyl Compounds / Q000494:pharmacology; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology
D001095:Arachidonic Acids; D010743:Phospholipids; D011453:Prostaglandins; D011457:Prostaglandins D; D011458:Prostaglandins E; D011460:Prostaglandins F; D011480:Protease Inhibitors; D014105:Tosyl Compounds; D014443:Tyrosine; D013929:Thromboxane B2; C002306:N-tosyllysine methyl ester; C007651:ethyl N-alpha-acetyl-tyrosinate; D008239:Lysine